<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR58" class="ref">
 <span class="label" xmlns="http://www.w3.org/1999/xhtml">58.</span>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">MÃ¼ller</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">RH</span>
   </name>
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Jacobs</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">C</span>
   </name>
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Kayser</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">O</span>
   </name>
  </person-group>
  <div class="article-title" xmlns="http://www.w3.org/1999/xhtml">Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future</div>
  <div class="source" xmlns="http://www.w3.org/1999/xhtml">Adv. Drug Deliv. Rev.</div>
  <span class="year" xmlns="http://www.w3.org/1999/xhtml">2001</span>
  <span class="volume" xmlns="http://www.w3.org/1999/xhtml">47</span>
  <span class="fpage" xmlns="http://www.w3.org/1999/xhtml">3</span>
  <span class="lpage" xmlns="http://www.w3.org/1999/xhtml">19</span>
  <span pub-id-type="doi" class="pub-id" xmlns="http://www.w3.org/1999/xhtml">10.1016/S0169-409X(00)00118-6</span>
  <?supplied-pmid 11251242?>
  <span pub-id-type="pmid" class="pub-id" xmlns="http://www.w3.org/1999/xhtml">11251242</span>
 </element-citation>
</ref>
